Investor Ideas
Potcasts 571, Cannabis News and Stocks on the Move; (OTC: $ROSN), (TSXV: $HITI.V)
(NASDAQ: $HITI), (TSX: $CWEB.TO) (OTCQX: $CWBHF), (NYSE: $HEXO) (TSX: $HEXO.TO)
Delta, Kelowna, BC, June 2, 2021 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/060221-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/06021ROSN-HITI-CWEB-HEXO.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
ROSINBOMB (OTC:ROSN), industry leading developer and
manufacturer of the highly acclaimed ROSINBOMB line of solventless extraction
presses and Industry Icon Tommy Chong, recently announced their exclusive
collaboration to offer consumers a custom Tommy-art skinned Rosinbomb Rocket.
In
celebration of the launch, Tommy was a featured guest on CannabisRadio.com’s
Blunt Business Show which can be heard here.
During
the interview Tommy expressed his excitement for this exclusive collaboration
in which his personal artwork and handwritten signature adorn each Rosinbomb
Tommy Chong Rocket, “This rosin press does everything people use to do
manually.” He stated., “This rosin press eliminates all the heavy labor, work,
time and everything else and you get the purest of the pure!” he added as
reference to Rosinbomb’s mission of enabling consumers to craft pure
solventless extract.
Rosinbomb’s
CEO, Fred Angelopoulos said, “Tommy Chong stands among the very few true
Industry and Cultural icons within our industry. He has touted the healing and
wellness benefits of cannabis for almost 50 years and has been a leader in the
industry.” Angelopoulos continued, “It has been our true pleasure and honor to
have partnered with Tommy on this project and we look forward to future
collaborations that celebrate Tommy, our products and the customers who
appreciate us both.”
Ryan
Mayer, Founder & President of Rosinbomb said, “Working with Tommy Chong is
a testament to his legacy and our future. We are overjoyed at the positive
response we’ve received from his fans and our collective customers. Mayer
added, “Tommy is a legend and we felt strongly that our first collaboration
with an influential figure in the industry should be with someone who is not
just an ‘influencer’ but who is and always will be an icon and a champion for
cannabis consumers the world over.”
The
Tommy Chong Rocket priced at $549, is a limited offering and the presses will
be individually hand signed by Tommy as part of a numbered collectible edition
available exclusively at www.rosinbomb.com.
ROSINBOMB
continues to be celebrated by experts and leading media outlets. Forbes.com
called the Rocket ‘Revolutionary Technology That Creates Perfect THC/CBD Rosin
Every time’ and Tech expert website Engadget named the Rocket ‘The Panini Press
Of Weed.’
To
view the complete line of Rosinbomb presses and accessories please visit http://www.rosinbomb.com.
To
view all the other exciting and engaging products from Tommy Chong. Please
visit https://tommychong.com.
High
Tide Inc. (TSXV: HITI) (NASDAQ: HITI), a retail-focused cannabis
corporation enhanced by the manufacturing and distribution of consumption
accessories, announced that the Company's common shares
commenced trading today on the Nasdaq Capital Market under the ticker symbol
"HITI". The Company's Nasdaq listing is expected to increase access
to investment in High Tide from retail and institutional investors around the
world. Furthermore, with access to a much larger capital market, the Company
expects to improve liquidity for its Common Shares and, in turn, optimize its
cost of capital.
High Tide continues to retain its
listing on the TSX Venture Exchange under the symbol "HITI". The
ticker used for the Common Shares traded on the OTC Markets quotation system
under the current symbol "HITID" has been seamlessly transferred to
the new ticker symbol "HITI".
Furthermore, as of today, High Tide
is the first major publicly traded cannabis retailer to begin trading on the
Nasdaq.
"The listing of the Common Shares
on the Nasdaq represents a milestone in the retail cannabis industry and
demonstrates the realization of our efforts in turning High Tide into a
first-class cannabis retailer," said Raj Grover, President and Chief
Executive Officer of High Tide. "High Tide's listing on the Nasdaq gives
us access to one of the world's largest capital markets and is in alignment
with our long-term goals of enhancing shareholder value by increasing
liquidity, optimizing our cost of capital, while furthering High Tide's appeal
to international and institutional investors," added Mr. Grover.
Charlotte's
Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp CBD
wellness products and a Certified B Corporation, today announced the collaboration of its CW
Labs division on a preclinical sleep and anxiety study with the University of
Colorado-Boulder's REACH (Research and Education Addressing Cannabis and
Health) Center. The scientific investigation uses the Company's full spectrum
hemp formulations with CBN (cannabinol) and CBD (cannabidiol) and levels of THC
below 0.3% to examine the impact on anxiety and sleep quality. The Company is the
only hemp CBD brand supporting the University of Colorado REACH Center's
milestone study.
There is limited published
preclinical or clinical data on phytocannabinoids other than CBD and THC,
especially their effect at levels available in commercially sold hemp-derived
CBD supplements. There is some anecdotal evidence on the ability of CBN to help
with sleep but little substantiated clinical or preclinical evidence to
validate these pervasive claims. Long term, it is anticipated that this study
will inform future clinical initiatives to better understand how specific
ratios of cannabinoids and different delivery formats are effective at
supporting improved sleep quality and instilling healthier sleep architecture
in humans.
"Charlotte's Web is committed
to advancing science on the benefits and safety of CBD and other hemp
phytocannabinoids through rigorous scientific investigations such as this sleep
and anxiety study," said Tim Orr, Senior Vice President of Charlotte's Web
and President of its CW Labs division, which currently has more than a dozen
scientific research studies underway.
"We're honored to team up with
CU's REACH Center to explore the potential impacts of full-spectrum hemp
extract with CBD and CBN on anxiety and sleep quality."
Monika Fleshner, PhD, Professor of
Integrative Physiology, and a member of the Center for Neuroscience at the
University of Colorado – Boulder is the project lead, and this preclinical
study will be conducted in her Stress Physiology Laboratory.
"There is a great need for
properly controlled experimental studies that are designed to test the
potential neural and physiological impacts of hemp derived phytocannabinoids.
With support from CU REACH and Charlotte's Web, our research will explore both
the efficacy and mechanisms of how these substances can affect complex
brain-mediated behavior, such as disturbed sleep."
HEXO Corp. (NYSE: HEXO) (TSX: HEXO) , an Ottawa, Ontario-headquartered
consumer packaging goods cannabis company, announced a definitive agreement to acquire
Redecan, Canada’s largest privately owned licensed producer. HEXO promoted the
C$925-million deal as one that will help propel the company to its goal of
being the No. 1 licensed producer by market share in Canada.
This
acquisition follows two other major deals by HEXO this year, including
all-share acquisitions of Zenabis Global Inc. to the tune of $235 million in
February and 48North Cannabis Corp. for $50 million earlier this month.
Founded
in 2013, HEXO’s $925-million acquisition of Redecan will be its largest deal
yet, CEO Sébastien St-Louis told Cannabis
Business Times.
“Well,
I’ve never been afraid of price tags,” he said. “What I look for is what’s the
fundamental value. [Redecan] had the best growth in the whole industry. So, 169
percent growth year-over-year. They’re the most profitable licensed producer in
the industry. And there was a beautiful product overlap. So, from that
perspective, it was a hard opportunity to say no to.”
When
the transaction closes—expected in the third quarter of 2021—HEXO will hold
approximately 17% of the adult-use market share in Canada, according to
St-Louis. That percentage, he believes, would provide HEXO a bigger piece of
the Canadian market than the Tilray-Aphria combo, which closed a megadeal
earlier this month, he said.
In
particular, HEXO will hold top market-share positions in Canada’s four largest
markets: Alberta, British Columbia, Ontario and Quebec. Those four provinces
represent approximately 85% of Canada’s population.
Under
the terms of their share purchase agreement, HEXO will pay Redecan shareholders
$400 million in cash and $525 million through the issuance of HEXO common
shares at an implied price of $7.53 per share.
Redecan
has not traditionally had access to the Quebec market, which is where HEXO was
founded. Meanwhile, Redecan is far ahead of HEXO in the Ontario market,
St-Louis said. From a distribution perspective, there are different retailers
and government entities that control those markets.
Also
making Redecan attractive to HEXO is its consumer loyalty, St-Louis said.
Redecan
is ranked No. 1 in the purchase-to-loyalty conversion metric, with 44% of
consumers who purchase Redecan indicating they would repurchase the brand,
according to Brightfield Group’s brand health portal for Canada. Redecan is
also ranked in the top 10 for converting consumers from awareness to purchase
rate, indicating an overall healthy funnel, according to Brightfield data that
is fielded quarterly via consumer survey and is normalized on age, gender and
province.
“Redecan’s
unwavering focus on the consumer, along with lean operating principles and
highly efficient automated manufacturing technology, have allowed us to
establish a significant presence in the Canadian market,” Redecan co-founder
Will Montour said in the press release announcing the acquisition. “We’ve now
entered a phase where scale is key, and our complementary consumer bases, brand
portfolios and distribution relationships can enhance financial performance.”
“We
really didn’t step on each other’s toes,” he said. “The crown jewel from an
intellectual property perspective is their ‘Redees.’ They have put together a
technology to make marijuana cigarettes that [are] the best in the world. So,
bringing that in as an offering that we then as HEXO can bring into the United
States is very exciting.”
HEXO
and Redecan’s combined strengths should provide a platform for global growth,
leveraging HEXO’s international reach, St-Louis said. HEXO already has a foot
in the U.S. market with CBD beverages available in Colorado under its Truss
Beverages brand.
While
the Canadian market has a bright future, HEXO is positioning itself for future
expansion in the U.S. and Europe with the intention of becoming one of the top
three largest cannabis companies in the world, St-Louis said.
“If
we just hold our market share in Canada, Canadian markets should grow two to
three times over the next few years,” he said. “So, there’s a lot of upside
just in Canada. But we’re quite focused on the United States right now. We
think that there’s an opportunity for us to take a lot of our intellectual
property and export that to the United States. So, [we want] to take our
product line and do things like pre-rolls for the multistate operators and do
things like hash for the multistate operators.”
The
acquisition is pending approval from the Competition Bureau Canada as well as
HEXO shareholder voters, which St-Louis said he foresees as favorable in
closing the transaction.
“Joining
the HEXO team will leverage our combined strengths and accelerate our growth
within Canada and internationally,” Redecan co-founder Pete Montour said in the
press release. “We look forward to building a leading global organization
together.”
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors
can trade these stocks and other ideas on our site
using our list of
top stock trading apps including
Robinhood , Acorn, Stash and others.
To hear
more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google Play
Music and most audio platforms available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto
Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
, Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for iPhone and Android
Join our
Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665
0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
